Apollo Intelligence

Canaccord Genuity Advises Healthcare Data and Insights Leader Apollo Intelligence on its Sale to Frazier Healthcare Partners

Canaccord Genuity is pleased to announce it has advised Apollo Intelligence, a leading provider of real-time data and insights to the healthcare and life science industries, on its sale to Frazier Healthcare Partners, a Seattle-based, healthcare-focused private equity firm.

Apollo Intelligence’s mission is to accelerate health innovation to improve life. The company was founded in 2019 by a group of experienced industry leaders and investors. The Apollo platform launched with its acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry, as the founding company. In 2020, the company acquired Survey Healthcare Global, a global market leader of first-party healthcare data collection and custom survey solutions, to complement InCrowd and strengthen its global reach. Through these innovative solutions, Apollo is executing its mission to accelerate health innovation to improve life—creating new, high-quality paths to research and insights.

Apollo’s unique integration of healthcare stakeholder access, powerful tech-enabled analytic tools, and domain expertise enables global healthcare organizations to develop, refine, and deliver life-changing innovations. Apollo provides access to 2 million healthcare stakeholders worldwide, including physicians, patients, caregivers, and allied healthcare professionals. Apollo’s 220+ employees support top global pharmaceutical brands, market research agencies, and consultancies across 13 different countries in the Americas, Europe, and Asia.

As a leader in providing rapid insights that accelerate time to market for life science companies, Apollo is at the forefront of technological innovation within healthcare market research. Apollo will continue to focus on elevating industry standards for research and data-driven insights. The new relationship with Frazier will fuel innovation and scale, extending Apollo’s value to healthcare and life science clients.

Founded in 1991, Frazier Healthcare Partners is a leading middle-market private equity firm focused exclusively on the healthcare sector. With over $7.1 billion in total capital raised, Frazier has invested in more than 200 companies with transaction types ranging from buyouts of profitable healthcare services companies to venture capital and company creation. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier has offices in Seattle, WA, and Menlo Park, CA, and invests broadly across the U.S., Canada, and Europe.

Frazier Executive in Residence, Vivek Sharma will join Apollo as Executive Chairman on Apollo’s Board of Directors. Mr. Sharma has extensive experience leading tech-enabled healthcare services organizations supporting the life science end market, including most recently as CEO of Decision Resources Group (DRG) before its sale to Clarivate. Frazier Center of Excellence Partner, Ken McLaren will similarly play a meaningful role in developing and executing Apollo’s growth strategy, leveraging his prior experiences as SVP of Data Analytics and Insights at Clarivate and chief strategy officer at DRG.